CD-70 is a protein upregulated on many hematologic and solid cancer cells that has been found to be highly expressed in MM cells of RRMM patients who have progressed on BCMA-directed therapies [123]. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.